CIN Screening & Management Deep Dive

Generated from prompt:

Recreate the 'CIN Screening, Evaluation & Management Deep Dive' presentation with a Modern Academic design in 16:9 wide format. Use a teal–white–purple color scheme, medical icons, WHO/FOGSI visuals, improved readability, section dividers, and professional transitions. Title slide: 'CIN Screening & Management – A Comprehensive Academic Review for Final Year MBBS'.

Modern academic 16:9 presentation (8 slides) on CIN for final-year MBBS. Covers agenda, risk factors/epidemiology, screening, evaluation/colposcopy, management workflow, and key takeaways using teal-w

December 24, 20258 slides
Slide 1 of 8

Slide 1 - CIN Screening & Management

This title slide introduces "CIN Screening & Management – A Comprehensive Academic Review for Final Year MBBS," focusing on a deep dive for final-year medical students. It includes the presenter's name and date in the subtitle.

CIN Screening & Management – A Comprehensive Academic Review for Final Year MBBS

Deep Dive for Final Year MBBS | Your Name | Date

Slide 1 - CIN Screening & Management
Slide 2 of 8

Slide 2 - Presentation Agenda

This agenda slide outlines the presentation structure on CIN, starting with an introduction, screening methods, and evaluation protocols. It continues with management strategies, WHO/FOGSI guidelines, case studies, and ends with key takeaways.

Presentation Agenda

  1. Introduction to CIN
  2. Screening Methods
  3. Evaluation Protocols
  4. Management Strategies
  5. WHO/FOGSI Guidelines
  6. Case Studies
  7. Key Takeaways

Source: CIN Screening, Evaluation & Management Deep Dive

Speaker Notes
Outline the key sections of the presentation to set expectations for the audience.
Slide 2 - Presentation Agenda
Slide 3 of 8

Slide 3 - CIN Screening & Management – A Comprehensive Academic Review for Final Year MBBS

This section header slide introduces "CIN" (Cervical Intraepithelial Neoplasia) as the first topic in a comprehensive academic review for final year MBBS students on CIN screening and management. It highlights the key focus areas: definition, risk factors, and epidemiology.

CIN Screening & Management – A Comprehensive Academic Review for Final Year MBBS

01

Introduction to CIN

Cervical Intraepithelial Neoplasia: Definition, Risk Factors, Epidemiology

Source: Recreated 'CIN Screening, Evaluation & Management Deep Dive' presentation

Speaker Notes
Introduce Cervical Intraepithelial Neoplasia (CIN): definition, risk factors, and epidemiology. Use purple divider with medical icon (e.g., cervix diagram or pap smear icon). Teal-white-purple scheme, 16:9 format, modern academic design.
Slide 3 - CIN Screening & Management – A Comprehensive Academic Review for Final Year MBBS
Slide 4 of 8

Slide 4 - Risk Factors & Epidemiology

Risk factors for the condition include high-risk HPV infection (types 16, 18), smoking, immunosuppression, and multiple sexual partners. Globally, there are 300,000 cases per year according to the WHO.

Risk Factors & Epidemiology

  • High-risk HPV infection (types 16, 18)
  • Smoking and immunosuppression
  • Multiple sexual partners
  • Global incidence: 300,000 cases/year (WHO)

Source: CIN Screening, Evaluation & Management Deep Dive

Speaker Notes
Highlight HPV 16/18 as primary cause; note global burden per WHO data.
Slide 4 - Risk Factors & Epidemiology
Slide 5 of 8

Slide 5 - Screening Methods

Screening methods for cervical cancer include Pap Smear for cytological detection of abnormal cells, HPV testing for high-risk strains like 16 and 18, and visual inspection techniques (VIA or VILI) suited for low-resource settings. Guidelines feature WHO-recommended screen-and-treat algorithms using VIA/HPV, along with FOGSI recommendations for HPV primary screening in women 30+ followed by cytological triage.

Screening Methods

Screening MethodsGuidelines & Algorithms

| • Pap Smear: Cytological detection of abnormal cervical cells

  • HPV Testing: Identifies high-risk oncogenic strains (16,18)
  • Visual Inspection: VIA (acetic acid) or VILI (iodine) for low-resource settings | • WHO-recommended: Screen-and-treat algorithms with VIA/HPV
  • FOGSI Guidelines: HPV primary screening for women 30+, triage with cytology

📊 Medical icons: Microscope (Pap), DNA helix (HPV), Eye (Visual) |

Source: CIN Screening, Evaluation & Management Deep Dive

Speaker Notes
Highlight primary screening modalities: Pap smear for cytology, HPV DNA testing for high-risk types, and visual inspection with acetic acid (VIA). Reference WHO algorithms for low-resource settings and FOGSI guidelines for India.
Slide 5 - Screening Methods
Slide 6 of 8

Slide 6 - Evaluation & Colposcopy

The slide outlines management for cervical intraepithelial neoplasia (CIN) grades. CIN1 (mild dysplasia) is managed by observation, while CIN2/3 (moderate/severe) requires biopsy and treatment.

Evaluation & Colposcopy

GradeFeaturesManagement
CIN1Mild dysplasiaObserve
CIN2/3Moderate/SevereBiopsy, Treatment

Source: CIN Screening Guidelines

Speaker Notes
CIN grading guides colposcopy-directed biopsy and management decisions.
Slide 6 - Evaluation & Colposcopy
Slide 7 of 8

Slide 7 - Management Workflow

The Management Workflow outlines cervical screening phases starting with Pap Smear/HPV Test by Primary Care/GP, progressing to Colposcopy and Biopsy by Gynae Oncologist for abnormalities, and LEEP/Cone Biopsy by Gynae Surgeon for high-grade CIN. Post-treatment follow-up with Cytology/Colposcopy occurs 6-12 months later under Gynae Oncologist, with specified durations for each step.

Management Workflow

Source: CIN Screening, Evaluation & Management Deep Dive

Speaker Notes
Step-by-step management workflow from screening to follow-up, with teal arrows indicating progression. Visualize as a flowchart with circular step icons.
Slide 7 - Management Workflow
Slide 8 of 8

Slide 8 - Key Takeaways & Q&A

Early screening saves lives, following WHO/FOGSI protocols with a multidisciplinary approach are the key takeaways. Thank you! Questions? Implement protocols in your practice today.

Key Takeaways & Q&A

<ul style='font-size: 28px; line-height: 1.4; color: #2E7D7D; margin: 20px 0;'> <li>Early screening saves lives</li> <li>Follow WHO/FOGSI protocols</li> <li>Multidisciplinary approach</li> </ul> <div style='font-size: 36px; color: #6A1B9A; font-weight: bold; margin: 40px 0;'>Thank you! Questions?</div> <div style='font-size: 24px; color: #555; margin-top: 20px;'>Contact info & references</div>

Closing Message: Act Now, Save Lives | Call-to-Action: Implement protocols in your practice today

Source: CIN Screening, Evaluation & Management Deep Dive

Speaker Notes
Summarize main points, open floor for questions, provide contacts and references.
Slide 8 - Key Takeaways & Q&A

Discover More Presentations

Explore thousands of AI-generated presentations for inspiration

Browse Presentations
Powered by AI

Create Your Own Presentation

Generate professional presentations in seconds with Karaf's AI. Customize this presentation or start from scratch.

Create New Presentation

Powered by Karaf.ai — AI-Powered Presentation Generator